Theyre portable, easy to use, and less expensive
The study established that four hour intravenous infusions of GLP-1 (7-36) completely normalised blood glucose levels of patients with type 2 diabetes admitted to hospital for insulin therapy (Nauck, Klein, rskov)
We know that researchers, from large institutions to independent pioneers, rely on our products to be exactly what they claim to be
Tirzepatide has substantially more long-term safety data given its earlier approval and wider use
Additional reported effects include antioxidant activity, genomic regulatory effects, and immune modulation [1]
The synthetic peptide is 3x more potent compared to standard Insulin-like Growth Factor 1 (IGF-1)